The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 22, 2022
Filed:
Oct. 27, 2015
Applicant:
Taipei Medical University, Taipei, TW;
Inventors:
Chien Huang Lin, Taipei, TW;
Jing-Ping Liou, Taipei, TW;
Shiow-Lin Pan, Taipei, TW;
Che-Ming Teng, Taipei, TW;
Assignee:
Taipei Medical University, Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61P 1/16 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61K 31/192 (2006.01); A61P 17/00 (2006.01); A61P 9/00 (2006.01); A61K 31/4412 (2006.01); A61P 1/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 45/06 (2006.01); A61K 31/435 (2006.01); A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 31/192 (2013.01); A61K 31/4412 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 17/00 (2018.01); A61K 31/435 (2013.01); A61K 31/497 (2013.01); A61K 2300/00 (2013.01);
Abstract
The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.